Predicting the Impact of Biocorona Formation Kinetics on Interspecies Extrapolations of Nanoparticle Biodistribution Modeling

References

• Lynch I , CedervallT , LundqvistM , Cabaleiro-LagoC , LinseS , DawsonKA . The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century . Adv. Colloid Interface Sci.134 , 167 – 174 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Monopoli MP , AbergC , SalvatiA , DawsonKA . Biomolecular coronas provide the biological identity of nanosized materials . Nat. Nanotechnol.7 , 779 – 786 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA , SambergME , OldenburgSJ , RiviereJE . Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations?Toxicol. Lett.220 , 286 – 293 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lesniak A , FenaroliF , MonopoliMP , AbergC , DawsonKA , SalvatiA . Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells . ACS Nano6 , 5845 – 5857 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pozzi D , ColapicchioniV , CaraccioloGet al. Effect of polyethyleneglycol (PEG) chain length on the bio–nano-interactions between pegylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells . Nanoscale6 , 2782 – 2792 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Park K . Facing the truth about nanotechnology in drug delivery . ACS Nano7 , 7442 – 7447 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Riviere JE . Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic?Nanomedicine (Lond.)8 , 1357 – 1359 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Eliasof S , LazarusD , PetersCGet al. Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle . Proc. Natl Acad. Sci.110 , 15127 – 15132 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Riviere JE . Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots . Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.1 , 26 – 34 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Moghimi SM , HunterAC , AndresenTL . Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective . Annu. Rev. Pharmacol. Toxicol.52 , 481 – 503 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Boxenbaum H . Time concepts in physics, biology, and pharmacokinetics . J. Pharmacol. Sci.75 , 1053 – 1062 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Dell’Orco D . The importance of the protein corona for successful nanodevice design and delivery . J. Nanomed. Biother. Discov.2 , e107 ( 2012 ).
   Google Scholar
• Casals E , PfallerT , DuschlA , OostinghGJ , PuntesV . Time evolution of the nanoparticle protein corona . ACS Nano4 , 3623 – 3632 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Xia XR , Monteiro-RiviereNA , RiviereJE . An index for characterization of nanomaterials in biological systems . Nat. Nanotechnol.5 , 671 – 675 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Caracciolo G , PozziD , CapriottiALet al. Evolution of the protein corona of lipid gene vectors as a function of plasma concentration . Langmuir27 , 15048 – 15053 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Dell’Orco D , LundqvistM , OslakovicC , CedervallT , LinseS . Modeling the time evolution of the nanoparticle–protein corona in a body fluid . PLoS ONE5 , e10949 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sahneh FD , ScoglioCM , RiviereJE . Dynamics of nanoparticle–protein corona complex formation: analytical results from population balance equations . PLoS ONE8 , e64690 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Dell’Orco D , LundqvistM , CedervallT , LinseS . Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening . Nanomed. Nanotech. Biol. Med.8 , 1271 – 1281 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Barran Berdon AL , PozziD , CaraccioloGet al. Time evolution of nanoparticle–protein corona in human plasma: relevance for targeted drug delivery . Langmuir29 , 6485 – 6494 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Mortensen NP , HurstG , WangW , FosterCM , NallathambyPD , RettererST . Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity . Nanoscale5 , 6372 – 6380 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Tenzer S , DocterD , KuharevJet al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology . Nat. Nanotechnol.8 , 772 – 781 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lundqvist M , StiglerJ , CedervallTet al. The evolution of the protein corona around nanoparticles: a test study . ACS Nano5 , 7503 – 7509 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Salvati A , PitekAS , MonopoliMPet al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface . Nat. Nanotechnol.8 , 137 – 143 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lee HA , LeavensTL , MasonSE , Monteiro-RiviereNA , RiviereJE . Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model . Nano Lett.9 , 794 – 799 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Li L , TangF , LiuHet al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy . ACS Nano4 , 6874 – 6882 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Riviere JE , ScoglioCM , SahnehFD , Monteiro-RiviereNA . Computational approaches and metrics required for formulating biologically realistic nanomaterial pharmacokinetic models . Comput. Sci. Discov.6 , 014005 ( 2013 ).
   Google Scholar